Used primarily in the management of type 2 diabetes mellitus, this compound helps control blood glucose levels by stimulating insulin release from the pancreas. It belongs to the class of sulfonylureas, which enhance pancreatic beta-cell activity. It is typically prescribed when diet and exercise alone are insufficient for glycemic control. Due to its long half-life, it allows for once-daily dosing, making it convenient for patients. However, because of the risk of prolonged hypoglycemia, especially in elderly or renally impaired individuals, its use has declined in favor of newer agents with better safety profiles. It may also be used off-label in the treatment of diabetes insipidus, particularly the central type, by increasing the renal response to antidiuretic hormone.